TechnoGenesys

We have identified a new class of class of small molecule kinase inhibitor (R)-9b, which has emerged a major therapeutic solution for prostate cancer

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location St. Louis, MO, USA
  • Currency USD
  • Founded July 2011
  • Employees 1
  • Incorporation Type C-corp
  • Website technogenesys.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free